Arterys Cardio DL vs AI-ECG Tracker

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Arterys Cardio DL

by Arterys (now part of Tempus)

AI-ECG Tracker

by Carewell Health

AI Verdict

Arterys Cardio DL is an AI tool focused on enhancing cardiac MRI analysis through automated ventricle segmentations and 4D Flow post-processing. In contrast, the AI-ECG Tracker specializes in AI-powered auto-analysis and diagnosis of 12-lead ECG data for various cardiac abnormalities. While both leverage AI to improve diagnostic efficiency in cardiology, they address different imaging modalities and specific clinical workflows.

Choose Arterys Cardio DL if…

Choose Arterys Cardio DL if your primary need is advanced, quantitative analysis of cardiac MRI studies. This cloud-based solution excels at automated ventricle segmentations, 4D Flow post-processing for blood flow visualization, and quantitative delayed enhancement analysis, significantly reducing interpretation time and enhancing diagnostic precision for complex cardiac imaging.

View Arterys Cardio DL →

Choose AI-ECG Tracker if…

Choose AI-ECG Tracker if you require rapid and highly accurate automated diagnosis of 12-lead electrocardiograms for a broad spectrum of common cardiac abnormalities. This tool is ideal for scenarios demanding quick insights into arrhythmias, myocardial ischemia, and other conditions, offering comprehensive diagnostic classifications with a preference for on-premise processing capabilities.

View AI-ECG Tracker →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Arterys Cardio DL	AI-ECG Tracker
Deployment	Cloud-based (SaaS), integrates with existing PACS or EHR, web-based zero-footprint viewer (Mac, PC, tablet, phone). [4, 7, 9, 13, 27]	Mobile app, intended for use by qualified healthcare professionals in hospitals and other healthcare facilities.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Arterys Cardio DL

Arterys Cardio DL is a cloud-based solution that offers automated, editable ventricle segmentations, drastically reducing cardiac MRI interpretation time from 30-60 minutes to seconds. This focus on rapid, user-controlled analysis for complex imaging directly enhances workflow efficiency and ease of use.

Clinical Value

Tie

Both tools are FDA-cleared and demonstrate high clinical value in their respective domains. Arterys Cardio DL enhances diagnostic accuracy for complex cardiac MRI analysis, including 4D Flow and Quantitative Delayed Enhancement. AI-ECG Tracker offers high accuracy (over 95%) for a broad range of common cardiac abnormalities detected via ECG, supporting 104 diagnostic classifications.

Pricing & Value

Tie

Neither Arterys Cardio DL nor AI-ECG Tracker provides publicly available pricing information. Without transparent pricing details for either product, it is impossible to conduct a meaningful comparison of their value propositions.

Enterprise Readiness

Arterys Cardio DL

Arterys Cardio DL explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), alongside its cloud-based, vendor-agnostic compatibility, which are strong indicators for enterprise integration and scalability. While AI-ECG Tracker mentions HIPAA compliance and BAA as 'likely' due to its operations, the explicit confirmation from Arterys provides a clearer advantage for enterprise adoption.

Innovation

Arterys Cardio DL

Arterys Cardio DL positions itself as part of 'the world's first internet platform for medical imaging' and leverages deep learning for advanced 4D Flow post-processing and quantitative delayed enhancement in cardiac MRI. This represents a significant leap in leveraging cloud AI for complex imaging analysis.

Support & Docs

AI-ECG Tracker

While both companies offer direct contact for support, Lepu Medical, the parent company of Shenzhen Carewell Electronics Co., explicitly provides a 'Download Center' and 'Video Center' under its services, suggesting a more structured and accessible repository of documentation and training resources.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Arterys Cardio DL	AI-ECG Tracker
Tool Name	Arterys Cardio DL	AI-ECG Tracker
Company	ARTERYS	Shenzhen Carewell Electronics Co.
Primary Modality/Analysis	Automated, editable ventricle segmentations for cardiac MRI analysis	AI-powered ECG auto-analysis and diagnosis
Core AI Functionality	Automated ventricle segmentations for cardiac MRI	AI-powered ECG auto-analysis and diagnosis for 16 cardiac classifications and 104 ECG diagnostic classifications
Analysis Speed	Rapid analysis (seconds vs. 30-60 minutes)	Rapid diagnosis in approximately 3 seconds

Videos

Demos, reviews, and walkthroughs featuring Arterys Cardio DL and AI-ECG Tracker.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What types of cardiac data do these AI tools analyze?

Arterys Cardio DL (Tool A) is designed for the analysis of cardiac MRI images, providing automated ventricle segmentations, 4D Flow post-processing for blood flow visualization, and quantitative delayed enhancement analysis. The AI-ECG Tracker (Tool B) specializes in the auto-analysis and diagnosis of 12-lead ECG data for various cardiac abnormalities.

What specific clinical analyses and diagnoses do these tools provide?

Arterys Cardio DL offers automated, editable ventricle segmentations for cardiac MRI, along with 4D Flow post-processing for blood flow visualization and quantification, and Quantitative Delayed Enhancement analysis. The AI-ECG Tracker provides AI-powered auto-analysis and diagnosis for 16 cardiac classifications and 104 ECG diagnostic classifications, covering common abnormalities like arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction.

How do these tools address regulatory compliance and data security?

Both Arterys Cardio DL and AI-ECG Tracker are FDA-cleared. Arterys Cardio DL is explicitly stated to be HIPAA compliant and has a Business Associate Agreement (BAA). For the AI-ECG Tracker, HIPAA compliance and BAA are stated as 'likely' given the company's operations in the US healthcare market and general privacy practices, though not explicitly for this specific product.

What are the reported performance metrics, such as speed and accuracy?

Arterys Cardio DL offers rapid analysis, reducing interpretation time from 30-60 minutes to seconds, and aims to enhance diagnostic accuracy. The AI-ECG Tracker provides a rapid diagnosis in approximately 3 seconds and boasts high accuracy, over 95%, for common cardiac abnormalities.

Can these tools integrate with existing clinical workflows or systems?

Arterys Cardio DL is a cloud-based platform with vendor-agnostic compatibility, suggesting flexibility in integration with existing PACS or EHR systems. The AI-ECG Tracker utilizes an on-premise AI-ECG Workstation and a Window-based professional ECG diagnostic client for review and report generation, along with a web-based management portal.